Penicillin in Scarlet Fever

Jersild, T

doi:10.1136/bmj.1.4545.318-c

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Multiple sclerosis is considered the most common cause of neurological disability while inflammatory lesions associated with MS may affect a large range of systems and cause a variety of neurological symptoms. 1,2 Multiple sclerosis presents between 20 and 40 years of age and the women are more susceptible than men. The exact pathophysiology of multiple sclerosis in not known but it seems to be autoimmune in nature.…”

Section: Introductionmentioning

confidence: 99%

A review: Pathophysiology, diagnosis and management of multiple sclerosis

Jain¹,

Shukla²,

Agrawal³

et al. 2021

IJPCA

View full text Add to dashboard Cite

Multiple Sclerosis (MS) is common, non-traumatic disability disease which affects young peoples. The incidence of multiple sclerosis is increasing worldwide with socioeconomic impact of the disease. Multiple sclerosis affect about more than 2 million people and currently it is incurable. The ratio of effect of MS in women and men is 2:1 respectively. Approx 250, 000-to 350,000 people are diagnosed with MS in the USA and about 10,000 new cases diagnosed each year. The epidemiology of Multiple sclerosis indicates that low serum levels of vitamin D, smoking, obesity and infection etc. are likely to play a role in disease development. In case of treatment of MS, it is divided three phases include: symptomatic, acute attack and disease modifying methods. In case of symptomatic around helping to maintain a patient's quality of life. Treatment of acute attack is centered on the treatment of exacerbations that affects a patient's functional ability. In disease modifying treatment focuses on the long term management of the disease with the goal to reduce relapse rates, lessen severity and to slow the progression of disability.

show abstract

Section: Introductionmentioning

confidence: 99%